Skinvisible SKVI
OTC SKVI
$0.20 +0.00 (+0.00%)
At close: Sep 8, 2026 · 4:00 PM EDT

Skinvisible (SKVI) EV to FCF (2010 - 2026)

Skinvisible's (SKVI) quarterly EV to FCF came in at 523.3 in Q2 2026, up 429.6% year-over-year from 98.81 in Q2 2025, and up 133.21% quarter-over-quarter from 1575.58 in Q1 2026.

Analysis

Skinvisible (SKVI) EV to FCF (2010 - 2026) Analysis & Trends

Skinvisible has disclosed EV to FCF across 17 years of filings, most recently posting 523.3 for Q2 2026.

  • In Q2 2026, EV to FCF rose 429.6% year-over-year to 523.3; the TTM figure through Jun 2026 stood at 294.57 (up 1520.69% YoY), while the FY2025 annual figure was 29.19, down 28.36% from the prior year.
  • EV to FCF came in at 523.3 for Q2 2026 at Skinvisible, up from 1575.58 in the prior quarter.
  • In the past five years, EV to FCF ranged from a high of 1542.73 in Q3 2025 to a low of 1575.58 in Q1 2026.
  • Average EV to FCF over 5 years is 7.91, with a median of 22.38 recorded in 2024.
  • Year-over-year, EV to FCF surged 759.63% in 2025 and tumbled 1501.41% in 2026.
  • Over 5 years, EV to FCF stood at 8.09 in 2022, then tumbled by 1064.76% to 94.28 in 2023, then dropped by 12.73% to 106.28 in 2024, then jumped by 690.88% to 627.98 in 2025, then slipped by 16.67% to 523.3 in 2026.
  • Per Business Quant data, the three most recent EV to FCF figures were 523.3 in Q2 2026, 1575.58 in Q1 2026, and 627.98 in Q4 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 648.23 Bn 627.47 Bn 17.26 Bn
2 AbbVie 443.69 Bn 437.12 Bn 12.70 Bn
3 Merck 368.29 Bn 361.15 Bn 12.21 Bn
4 Novartis Ag 270.18 Bn 262.49 Bn 11.24 Bn
5 Pfizer 158.57 Bn 146.88 Bn 10.94 Bn
6 Sanofi 52.93 Bn 45.55 Bn 10.79 Bn
7 Revolution Medicines 44.15 Bn 44.15 Bn -
8 Incyte 25.21 Bn 20.68 Bn 1.57 Bn
9 United Therapeutics 21.11 Bn 18.44 Bn 683.80 Mn
10 Skinvisible 1.08 Mn 1.08 Mn 5,000.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 523.30
Mar 31, 2026 -1,575.58
Dec 31, 2025 627.98
Sep 30, 2025 1,542.73
Jun 30, 2025 -158.77
Mar 31, 2025 -98.39
Dec 31, 2024 -106.28
Sep 30, 2024 -233.88
Jun 30, 2024 -130.31
Mar 31, 2024 -25.20
Dec 31, 2023 -94.28
Sep 30, 2023 -65.82
Jun 30, 2023 -17.60
Mar 31, 2023 -6.39
Dec 31, 2022 -8.09
Sep 30, 2022 -19.57
Jun 30, 2022 2.34
Mar 31, 2022 -13.80
Dec 31, 2021 6.65
Sep 30, 2021 6.81